Cholesterol* HDL cholesterol* LDL cholesterol* Triglycerides* Glucose*
ARV
Lipohypertrophy          
No 179.9 ± 2.2 51.0 ± 0.7 100.2 ± 1.9 150.2 ± 5.9 86.1 ± 1.5
Yes 195.7 ± 2.2 52.7 ± 0.7 108.4 ± 1.9 185.4 ± 5.8 90.2 ± 1.5
P-value < 0.001 0.09 0.002 < 0.001 0.05
Lipoatrophy          
No 195.6 ± 2.4 52.4 ± 0.8 108.8 ± 2.1 175.6 ± 6.5 89.8 ± 1.6
Yes 182.2 ± 2.0 51.1 ± 0.7 101.1 ± 1.7 162.4 ± 5.5 87.0 ± 1.4
P value <0.001 0.09 0.005 0.1 0.2
Lipodystrophy          
No 188.5 ± 3.5 52.4 ± 1.1 104.8 ± 2.9 162.5 ± 9.2 86.0 ± 2.3
Yes 187.7 ± 1.8 51.7 ± 0.6 104.2 ± 1.5 169.4 ± 4.7 88.7 ± 1.2
P value 0.8 0.6 0.9 0.5 0.3
ARV naïve
Lipohypertrophy          
No 169.8 ± 2.2 49.0 ± 0.8 98.6 ± 2.0 112.3 ± 3.9 81.6 ± 1.4
Yes 180.5 ± 2.8 51.2 ± 1.0 103.2 ± 2.5 134.0 ± 4.9 88.7 ± 1.7
P-value 0.003 0.08 0.2 0.001 0.001
Lipoatrophy          
No 171.7 ± 2.4 49.1 ± 0.9 98.7 ± 2.1 118.1 ± 4.1 84.8 ± 1.5
Yes 176.3 ± 2.7 50.7 ± 1.0 102.5 ± 2.4 123.8 ± 4.7 83.6 ± 1.7
P-value 0.2 0.2 0.3 0.4 0.6
Lipodystrophy          
No 168.9 ± 3.0 49.3 ± 1.1 97.0 ± 2.6 110.5 ± 5.2 80.9 ± 1.8
Yes 176.3 ± 1.2 50.1 ± 0.8 102.2 ± 2.0 126.1 ± 3.8 86.2 ± 1.3
P-value 0.047 0.6 0.1 0.02 0.02
*mg/dL
**Adjusted for age, skin color, smoking status, and time since HIV diagnosis        
Table 5: Metabolic profile (mean ± SEM) of HIV-infected patients with lipodystrophy**.